Skip to main content
Anastasia Christensen

Anastasia Christensen

Anastasia Christianson, Ph.D., Managing Principal at EPAM Systems and former VP/Global Head of AI, ML, Analytics and Data at Pfizer, focusing on AI in life sciences and drug development.

Sep 9, 2026

20:32
Do you have any thoughts for us?
20:33
Yeah, there are differences for sure.
20:37
Of course, startups learn from the larger pharmas.
20:40
I think there's benefit for large pharmas learning from smaller companies as well.
20:45
So the smaller companies are smaller.
20:48
They work more And I don't mean that in a negative way, but rather that they are much more aware of cost and versatility and they have less roles.
20:58
One person does two or three different roles.

6 MINS LATER

26:43
For some of those leaders and entrepreneurs trying to implement AI strategies today, what advice would you give them to ensure their efforts are tied to measurable business outcomes rather than just experimentation? Do you have any thoughts for us there?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.